Your session is about to expire
← Back to Search
Gastric Bypass and Sleeve Gastrectomy for Hypoglycemia
Study Summary
This trial will study how well two types of weight-loss surgery, gastric bypass and sleeve gastrectomy, improve glucose metabolism by looking at neural and hormonal factors.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can travel to Cedars-Sinai Medical Center for the study.I am not on medications that interact with atropine or can stop them if needed.I have a history of glaucoma.I am unable to understand and agree to the study's procedures and risks.I have myasthenia gravis.I have an enlarged prostate.I have had weight loss surgery and feel no symptoms.You have low levels of hemoglobin in your blood.I have uncontrolled high blood pressure or cholesterol.I have type 2 diabetes.I am healthy, have never had surgery, and do not have diabetes.I am healthy, not planning surgery, and have diabetes.I have high blood pressure over 140/90 and problems with my cholesterol.I have a brain condition.I have an active heart, lung, liver, GI, or kidney disease.I have had low blood sugar levels below 50 mg/dl after gastric bypass surgery.I have had gastric bypass surgery and am experiencing severe blockage or diarrhea.
- Group 1: Exendin-(9-39)
- Group 2: Atropine
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What medical maladies is Atropine employed to address?
"Atropine is a medication that can be employed to treat an array of conditions, including uncontrollable laughter, rhinorrhoea, and abnormal dilation of the pupils. Additionally, it can also aid in the secretion of bile fluid."
Are there any other scientific investigations involving Atropine?
"Currently, 22 Atropine clinical trials are in progress and 6 of them have reached Phase 3. Most of the studies are located in Shanghai, but there is a total of 149 sites administering this medication across the globe."
Are applications currently being accepted for this research initiative?
"Affirmative. According to the clinicaltrials.gov webpage, this trial that was first announced on July 1st 2015 is recruiting participants. 200 individuals are needed from 2 hospitals for enrolment in the study."
Does your study accept participants who are 25 years of age or older?
"This clinical trial states that the lowest age for participation is 18 and the highest permissible age for enrollment is 65."
Approximately how many participants are enrolled in this research endeavor?
"Affirmative. Evidenced from the clinicaltrials.gov website, this medical investigation is currently in search of participants; first posted on July 1st 2015 and most recently updated November 1st 2022. The trial requires 200 individuals to participate at 2 separate sites."
Who is eligible to enroll in this research project?
"This medical trial seeks 200 participants between the ages of 18 and 65 who currently have bypass, gastric. In addition to this criteria, these patients must display evidence of hypoglycemia (blood glucose <50 mg/dl), be able to physically come to Cedars-Sinai Medical Centre for treatment, show no symptoms associated with bariatric surgery or diabetes, and not have a personal history of diabetes."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger